相关实验视频

Updated: May 26, 2025

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

抗血栓药物是否在偏头痛预防中发挥作用? 一个系统的审查

Federico De Santis¹, Matteo Foschi¹, Michele Romoli²

¹Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

|February 24, 2025

概括

抗血栓药物在一般人群中对偏头痛预防的证据不足. 有限的数据表明,在特定群体中存在潜在的益处,因此需要进一步研究.

科学领域:

神经学神经学
药理学药理学是指药理学的学科.
心血管研究研究心血管研究

背景情况:

抗血栓药物有时被认为是偏头痛的预防,特别是在患有频繁的光环, patent foramen ovale或前血栓状况的患者中.
进行了一项系统性审查,以评估抗血栓剂在预防偏头痛方面的有效性.
本综述讨论了针对频繁偏头痛或特定血管风险因素的个体的抗血栓药物的临床考虑.

研究的目的:

系统地审查和综合有关抗血栓药物在偏头痛预防中的作用的现有证据.
评估抗血小板和抗凝剂作为偏头痛预防治疗的疗效.
确定可能受益于偏头痛抗血栓治疗的特定患者群体.

主要方法:

在PubMed和Scopus上进行了系统的文献搜索,包括对抗血小板或抗凝剂预防偏头痛的观察和干预研究.
包括到2024年6月30日发表的研究,以及来自Clinicaltrials.gov.gov的正在进行的试验.
质量评估使用了RCT的Cochrane风险偏差2 (RoB-2) 和观察性研究的ROBINS-I;该协议已在PROSPERO注册.

主要成果:

确定了12个RCT和8个观察性研究,调查了预防偏头痛的抗血栓药物.
由于数据异质性,没有进行元分析可行;研究测试了乙撒利酸 (ASA),克洛皮多格雷尔,双抗血小板治疗和维生素K对抗剂.
整体疗效尚未明确证明,但有限的证据表明,抗血小板药物,主要是ASA,在特定人群中具有潜在的益处,如男性,患有偏头痛与光环的人以及患有 patent foramen ovale.

结论:

目前的证据不足以支持抗血栓药物对普通偏头痛患者的有效性.
初步发现表明,在精选的患者群体中,通过改善血管功能来获得潜在的间接益处.
进一步的随机对照试验 (RCT) 是有必要的,以调查抗血栓剂在这些特定人群中的疗效.

关键词:

这是一种抗血栓的抗血栓药物.艾拉艾拉艾拉艾拉微栓塞的发生是微栓塞.偏头痛偏头痛偏头痛偏头痛预防性治疗预防性治疗一个原血栓状的状态.

更多相关视频

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Dural Stimulation and Periorbital von Frey Testing in Mice As a Preclinical Model of Headache

Published on: July 29, 2021

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Author Spotlight: Deciphering Electrical Networks Behind Complex Brain Activities and Disorders

Published on: November 1, 2024

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Antidepressant Drugs: MAOIs and Other Agents

Antidepressant Drugs: MAOIs and Other Agents

Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...

Antianginal Drugs: Nitrates and β-Blockers

Antianginal Drugs: Nitrates and β-Blockers

In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....